Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Minocycline, experimental MS treatments | Multiple Sclerosis News Today | illustration of hands holding oral medicines

Minocycline for Multiple Sclerosis

Last updated April 6, 2022, by Marta Figueiredo, PhD

Fact-checked by Ines Martins, PhD

FAQs about minocycline in MS

Minocycline is an antibiotic that is also believed to have anti-inflammatory and neuroprotective effects. It is being evaluated in clinical trials in relapsing-remitting multiple sclerosis and clinically isolated syndrome. Results have shown that it may help slow disease progression and reduce relapses in MS patients by lowering disease-associated inflammation and subsequent nerve cell death.

Minocycline has shown promising results in MS Phase 2 and Phase 3 trials. These results may encourage the launch of additional studies to confirm the antibiotic’s benefits in relapsing forms of MS. It may still take several years before a potential approval is granted by the U.S. Food and Drug Administration.

Based on animal data, minocycline is not recommended for use during pregnancy due to possible fetal harm. People of childbearing age should use effective contraception while on this medication. Patients should talk with their healthcare provider if they become pregnant, plan to become pregnant, or are breastfeeding or plan to do so while on minocycline.

In clinical trials in multiple sclerosis patients, the earliest signs of minocycline’s effects were reported at six months. In one small trial involving 10 patients with relapsing-remitting MS, the treatment significantly lowered the number of inflammatory lesions by 84% at six months. In a larger trial, called MinoCIS, the antibiotic also significantly lowered the proportion of patients converting from clinically isolated syndrome to clinically definite MS at six months.

Hair loss and weight gain have not reported as side effects of minocycline in clinical trials for multiple sclerosis, but hair loss is mentioned as a common side effect of minocycline in other indications. Patients should talk with their healthcare team if such events occur.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Related Articles


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.